mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Majumder, Pradip K, Febbo, Phillip G, Bikoff, Rachel, Berger, Raanan, Xue, Qi, McMahon, Louis M, Manola, Judith, Brugarolas, James +5 more·2004·Nature Medicine

DOI 10.1038/nm1052

Cited by (962)

Items 601–700 of 962

Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors
Özgür Şahin, Qingfei Wang, Samuel W. Brady, Kenneth Ellis, Hai Wang, Chia‐Chi Chang, Qingling Zhang, Preety Priya, Rui Zhu, Stephen T. C. Wong et al. · 2014 · Cell Research
An explorative analysis of the prognostic value of lactate dehydrogenase for survival and the chemotherapeutic response in patients with advanced triple-negative breast cancer
Zhenya Jia, Jian Zhang, Zhonghua Wang, Biyun Wang, Leiping Wang, Jun Cao, Zhonghua Tao, Xichun Hu · 2018 · Oncotarget
Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo
Laura Terraneo, Paola Bianciardi, Anna Caretti, Raffaella Ronchi, Michele Samaja · 2010 · The Prostate
Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells
Daniele Avancini, Alessandro Testori, Lucia Fresolone, Grazia Andolfi, Michela Vuono, Vittorio Martinelli, Francesca R. Santoni de Sio, Silvia Gregori · 2023 · Cell Reports
Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer
Jun Yang, Adrian Llewellyn Harris, Andrew M. Davidoff · 2018 · International Journal of Molecular Sciences
Short-Chain Fatty Acid Production and Functional Aspects on Host Metabolism
Bryan C. Tungland · 2018 · Elsevier eBooks
Increased Extracellular Adenosine in Radiotherapy-Resistant Breast Cancer Cells Enhances Tumor Progression through A2AR-Akt-β-Catenin Signaling
Hana Jin, Jong-Sil Lee, Dong Chul Kim, Young-Shin Ko, Gyeong‐Won Lee, Hye Jung Kim · 2021 · Cancers
Evidence of mTOR Activation by an AKT-Independent Mechanism Provides Support for the Combined Treatment of PTEN-Deficient Prostate Tumors with mTOR and AKT Inhibitors
Weisheng Zhang, Brian B. Haines, Clay L. Efferson, Joe Jiang Zhu, Chris Ware, Kaiko Kunii, Jennifer G. Tammam, Minilik H. Angagaw, Marlene C. Hinton, Heike Keilhack et al. · 2012 · Translational Oncology
Everolimus in colorectal cancer
Ivy P. Altomare, Herbert I. Hurwitz · 2013 · Expert Opinion on Pharmacotherapy
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease
Ning Zhao, Shalini Chopra, Kai R. Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran, Hyun‐Jung Kim, Jie Zhou, Shion An Lim, Kevin Leung et al. · 2022 · Clinical Cancer Research
Expression of phosphorylated-mTOR during the development of prostate cancer
Sarah Sutherland, Ruth Pe Benito, Susan M. Henshall, Lisa Glen Horvath, James G. Kench · 2014 · The Prostate
Targeting the Mammalian Target of Rapamycin in Lung Cancer
Glenn W. Vicary, Jesse Roman · 2016 · The American Journal of the Medical Sciences
Phase 1 Trial of Everolimus and Radiation Therapy for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
Vivek Narayan, Neha Vapiwala, Rosemarie Mick, Pearl Subramanian, John Paul Christodouleas, Justin E. Bekelman, Curtiland Deville, Ramji Ramaswamy Rajendran, Naomi Balzer Haas · 2016 · International Journal of Radiation Oncology*Biology*Physics
Assessing the Current State of Lung Cancer Chemoprevention: A Comprehensive Overview
Md Ashraf-Uz-Zaman, Aditya Bhalerao, Constantinos Marios Mikelis, Luca Cucullo, Nadezhda German · 2020 · Cancers
Dual PI3K/mTOR inhibitor, XL765 (SAR245409), shows superior effects to sole PI3K [XL147 (SAR245408)] or mTOR [rapamycin] inhibition in prostate cancer cell models
Giovanni Luca Gravina, Andrea Mancini, Luca Scarsella, Alessandro Colapietro, Ana Jitariuc, Flora Vitale, Francesco Marampon, Enrico Ricevuto, Claudio Festuccia · 2015 · Tumor Biology
Future Directions in the Treatment of Hormone-Sensitive Advanced Breast Cancer: The RAD001 (Everolimus)-Letrozole Clinical Program
Heidi A. Lane, David Lebwohl · 2006 · Seminars in Oncology
New drugs in prostate cancer
Andrew J. Armstrong, Michael Anthony Carducci · 2006 · Current Opinion in Urology
Application of Oligonucleotide Microarrays to Assess the Biological Effects of Neoadjuvant Imatinib Mesylate Treatment for Localized Prostate Cancer
Phillip G. Febbo, Aaron R. Thorner, Mark A. Rubin, Massimo F. Loda, Philip W. Kantoff, William K. Oh, Todd R. Golub, Daniel J. George · 2006 · Clinical Cancer Research
A short review on cross-link between pyruvate kinase (PKM2) and Glioblastoma Multiforme
Harkomal Verma, Ravi P. Cholia, Sharanjot Kaur, Monisha Dhiman, Anil Kumar Mantha · 2021 · Metabolic Brain Disease
Identification and experimental validation of ferroptosis-related gene SLC2A3 is involved in rheumatoid arthritis
Jing Xiang, Haiqing Chen, Zhiping Lin, Jian Chen, Lianxiang Luo · 2023 · European Journal of Pharmacology
Drug Efficacy Testing in Mice
William Y. Kim, Norman E. Sharpless · 2010 · Current topics in microbiology and immunology
Everolimus and Long-Term Outcomes in Renal Transplantation
Josep Maria Campistol, Johan Willem de Fijter, Björn Nashan, Hallvard Holdaas, Stefan Vitko, Christophe M. Legendre · 2011 · Transplantation
Involvement of the PI3K/AKT pathway in the hypoglycemic effects of saponins from Helicteres isora
Shefalee K. Bhavsar, Michael Föller, Shuchen Gu, Sanjay Vir, Mamta B. Shah, Kamlesh K. Bhutani, Dev D. Santani, Florian J.W. Lang · 2009 · Journal of Ethnopharmacology
Interplay between receptor tyrosine kinases and hypoxia signaling in cancer
Astrid A. Glück, Daniel M. Aebersold, Yitzhak Zimmer, Michaela Medová · 2015 · The International Journal of Biochemistry & Cell Biology
Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes
Olusola Olalekan Elekofehinti, Olaposi Idowu Omotuyi, Jean Paul Kamdem, Oluwamodupe Cecilia Ejelonu, Vanessa Guimarães Alves Olher, Isaac Gbadura Adanlawo, João Batista Teixeira da Rocha · 2014 · Journal of Physiology and Biochemistry
DART: Denoising Algorithm based on Relevance network Topology improves molecular pathway activity inference
Yan Jiao, Katherine Lawler, Gargi Surendra Patel, Arnie D. Purushotham, Annette F Jones, Anita E. Grigoriadis, Andrew N.J. Tutt, Tony Ng, Andrew Erich Teschendorff · 2011 · BMC Bioinformatics
The role of miR-24 as a race related genetic factor in prostate cancer
Yutaka Hashimoto, Marisa Shiina, Taku Kato, Soichiro Yamamura, Yuichiro Tanaka, Shahana Majid, Sharanjot Saini, Varahram Shahryari, Priyanka Kulkarni, Pritha Dasgupta et al. · 2017 · Oncotarget
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
Yuyang Pang, Tingxun Lu, Zijun Yidan Xu-Monette, Ken H. Young · 2023 · International Journal of Molecular Sciences
The Clinicopathologic Importance of Serum Lactic Dehydrogenase in Patients with Gastric Cancer
Zhi Zhao, Fanghai Han, Shibin Yang, Lixin Hua, Jian-Hai Wu, Wenhua Zhan · 2014 · Disease Markers
Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T‐cell leukemia/lymphoma and apoptosis in peripheral T‐cell lymphomas
Nadine Darwiche, Ansam F. Sinjab, Ghada Abou‐Lteif, Mirella Bou Chedid, Olivier Hermine, Ghassan S. Dbaibo, Ali A. Bazarbachi · 2010 · International Journal of Cancer
Loss of Inhibitory Insulin Receptor Substrate-1 Phosphorylation Is an Early Event in Mammalian Target of Rapamycin–Dependent Endometrial Hyperplasia and Carcinoma
Adrienne S. McCampbell, Heather A. Harris, Judy S. Crabtree, Richard C. Winneker, Cheryl Lyn Walker, Russell R. Broaddus · 2010 · Cancer Prevention Research
Impact of viral presence in tumor on gene expression in non-small cell lung cancer
Youngchul Kim, Christine M. Pierce, Lary A. Robinson · 2018 · BMC Cancer
Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus
Shanshan Wei, S Xie, Zhenghui Yang, Xiaohong Peng, L Gong, Ke‐seng Zhao, Kang Zeng, Kuan Lai · 2018 · Lupus
Fundamentals of Molecular Imaging: Rationale and Applications With Relevance for Radiation Oncology
Heiko M. Schöder, Seng Chuan Ong · 2008 · Seminars in Nuclear Medicine
Resolution of chronic inflammation and cancer
Gülçin Tezcan, Nil Yakar, Hatice Hastürk, Thomas E. Van Dyke, Alpdoğan Kantarcı · 2024 · Periodontology 2000
AMPK Control of mTOR Signaling and Growth
Dana M. Gwinn, Reuben J. Shaw · 2010 · The Enzymes
Switch in Signaling Control of mTORC1 Activity After Oncoprotein Expression in Thyroid Cancer Cell Lines
Roberta Malaguarnera, Kuan-Yuan Chen, Tae Yong Kim, José Miguel Domínguez, Francesca A. Voza, Bin Ouyang, Sushil Vundavalli, Jeffrey A. Knauf, James A. Fagin · 2014 · The Journal of Clinical Endocrinology & Metabolism
Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer
Christine Agnes Ciunci, Rodolfo F. Perini, Anjali Narayan Avadhani, HyunSeon Christine Kang, Weijing Sun, Maryann Redlinger, Kathleen Harlacker, Keith T. Flaherty, Bruce J. Giantonio, Mark Alan Rosen et al. · 2013 · Cancer
Βeta-glucan stimulation induces trained immunity markers in common carp, Cyprinus carpio
David Waikhom, Kezhedath Jeena, Rahul Krishnan, Tincy Varghese, Pani Prasad Kurcheti, Rajendran Kooloth Valappil · 2022 · Fish & Shellfish Immunology
Everolimus downregulates STAT3/HIF-1α/VEGF pathway to inhibit angiogenesis and lymphangiogenesis in TP53 mutant head and neck squamous cell carcinoma (HNSCC)
Md Maksudul Alam, Janmaris Marin Fermin, Mark Knackstedt, Mackenzie J. Noonan, Taylor Powell, Landon Goodreau, Emily K. Daniel, Xiaohua Rong, Tara Moore‐Medlin, Alok R. Khandelwal et al. · 2023 · Oncotarget
Development of animal models underlining mechanistic connections between prostate inflammation and cancer
Murielle Mimeault · 2013 · World Journal of Clinical Oncology
Breast cancer tissue slices as a model for evaluation of response to rapamycin
Stana Helena Giorgi Grosso, Maria Lúcia Hirata Katayama, Rosimeire Aparecida Roela, Suely Nonogaki, Fernando Augusto Soares, Helena Brentani, Leandro A. Lima, Maria Aparecida Azevedo Koike Folgueira, Ângela Flávia Logullo Waitzberg, Fátima Solange Pasini et al. · 2013 · Cell and Tissue Research
Canine CD4+ T‐cell lymphoma identified by flow cytometry exhibits a consistent histomorphology and gene expression profile
Lauren J. Harris, Kelly L. Hughes, Eugene J. Ehrhart, Julia Labadie, Janna A. Yoshimoto, Anne C. Avery · 2019 · Veterinary and Comparative Oncology
Biological Role of AKT and Regulation of AKT Signaling Pathway by Thymoquinone: Perspectives in Cancer Therapeutics
Md. Junaid, Yeasmin Akter, Syeda Samira Afrose, Mousumi Tania, Md. Asaduzzaman Khan · 2020 · Mini-Reviews in Medicinal Chemistry
Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone‐refractory prostate cancer
Robert G. Uzzo, Naomi Balzer Haas, Paul L. Crispen, Vladimir M. Kolenko · 2008 · Cancer
mTOR signaling regulates multiple metabolic pathways in human lung fibroblasts after TGF-β and in pulmonary fibrosis
Kun Woo D Shin, Volkan Atalay, Rengül Çetin-Atalay, Erin M O’Leary, Mariel Glass, Jennifer C. Houpy Szafran, Parker S. Woods, Angelo Y. Meliton, Obada R. Shamaa, Yufeng Tian et al. · 2025 · American Journal of Physiology-Lung Cellular and Molecular Physiology
Glucose Metabolism Measured by [18F]Fluorodeoxyglucose Positron Emission Tomography Is Independent of PTEN/AKT Status in Human Colon Carcinoma Cells
Quang‐Dé Nguyen, Meg Perumal, Todd A. Waldman, Eric Ofori Aboagye · 2011 · Translational Oncology
Rationally co-targeting divergent pathways in KRAS wild-type colorectal cancers by CANscript technology reveals tumor dependence on Notch and Erbb2
Nilesh Brijwani, Misti Jain, Muthu Dhandapani, Farrah Zahed, Pragnashree Mukhopadhyay, Manjusha Biswas, Deepak Khatri, Vinod D. Radhakrishna, Biswanath Majumder, Padhma Radhakrishnan et al. · 2017 · Scientific Reports
Alleviation of cisplatin-induced neuropathic pain, neuronal apoptosis, and systemic inflammation in mice by rapamycin
Moureq Rashed Alotaibi, Faten Abdullah Alaqil, Faleh Alqahtani, Miteb Alanazi, Ahmed Nadeem, Sheikh F. Ahmad, Rebeca Lapresa, Metab Alharbi, Abdulrahman Alshammari, Muteb Alotaibi et al. · 2022 · Frontiers in Aging Neuroscience
The PI3K/Akt/mTOR Pathway in Ovarian Cancer: Biological Rationale and Therapeutic Opportunities
Alexandra F. Leary, Édouard Auclin, Patricia Pautier, C. Lhommé · 2013 · InTech eBooks
One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Matteo Antonio Russo, Luigi Sansone, Ilaria Carnevale, Federica Limana, Alessandra Runci, Lucia Polletta, Giulietta Anna Perrone, Elena De Santis, Marco Tafani · 2015 · Endocrine Metabolic & Immune Disorders - Drug Targets
Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia (Review)
Camilla Evangelisti, Cecilia Evangelisti, Francesca Chiarini, Annalisa Lonetti, Francesca Buontempo, Daniela Bressanin, Alessandra Cappellini, Ester Orsini, James Andrew McCubrey, Alberto Maria Martelli · 2014 · International Journal of Oncology
Phase I and pharmacokinetic study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced solid malignancies
Maarten J. Deenen, Heinz‐Josef Klümpen, Dick J. Richel, Rolf W. Sparidans, Mariëtte J. Weterman, Jos H. Beijnen, Jan H.M. Schellens, Johanna W. Wilmink · 2011 · Investigational New Drugs
Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers
Padhma Radhakrishnan, Baraneedharan Ulaganathan, Subhadra Veluchamy, Muthu Dhandapani, Dency D. Pinto, Saravanan Thiyagarajan, Allen Thayakumar, Arun Prasath, Kamal A, Ayyappan Velu et al. · 2013 · Cancer Research
RUNX2 overexpression and PTEN haploinsufficiency cooperate to promote CXCR7 expression and cellular trafficking, AKT hyperactivation and prostate tumorigenesis
Yang Bai, Yinhui Yang, Yuqian Yan, Jian Zhong, Alexandra M. Blee, Yunqian Pan, Tao Ma, Robert Jeffrey Karnes, Rafael E. Jiménez, Wanhai Xu et al. · 2019 · Theranostics
Dual-drug loaded micelle for combinatorial therapy targeting HIF and mTOR signaling pathways for ovarian cancer treatment
Bhuvana Shyam Doddapaneni, Adel M. Al Fatease, Deepa A. Rao, Adam W. G. Alani · 2019 · Journal of Controlled Release
Signalling transduction of O-GlcNAcylation and PI3K/AKT/mTOR-axis in prostate cancer
Vivek Makwana, Santosh Rudrawar, Shailendra Anoopkumar‐Dukie · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Unveiling the Role of Mechanistic Target of Rapamycin Kinase (MTOR) Signaling in Cancer Progression and the Emergence of MTOR Inhibitors as Therapeutic Strategies
Devashish Mehta, Kajal Rajput, Dolly Jain, Avinash Bajaj, Ujjaini Dasgupta · 2024 · ACS Pharmacology & Translational Science
Recent developments in prostate cancer biomarker research: therapeutic implications
Sujitra Detchokul, Albert G. Frauman · 2010 · British Journal of Clinical Pharmacology
Paradoxical Regulation of Hypoxia Inducible Factor-1α (HIF-1α) by Histone Deacetylase Inhibitor in Diffuse Large B-Cell Lymphoma
Savita Bhalla, Andrew M. Evens, Sheila Prachand, Paul T. Schumacker, Leo I. Gordon · 2013 · PLoS ONE
Targeting metastatic castration-resistant prostate cancer: mechanisms of progression and novel early therapeutic approaches
Vittore Cereda, Vincenzo Formica, Gioia Massimiani, Livia Tosetto, Mario Roselli · 2014 · Expert Opinion on Investigational Drugs
Antineoplastic effects of mammalian target of rapamycine inhibitors
Maurizio Salvadori · 2012 · World Journal of Transplantation
Growth hormone receptor disrupts glucose homeostasis via promoting and stabilizing retinol binding protein 4
Jinxin Liu, Chenzhipeng Nie, Lamei Xue, Ying Yan, Shengnan Liu, Juan Sun, Mingcong Fan, Haifeng Qian, Hao Ying, Li Wang et al. · 2021 · Theranostics
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors
Bopei Cui, Lifang Song, Qian Wang, Kelei Li, Qian He, Wu Xing, Fan Gao, Mingchen Liu, Chaoqiang An, Qiushuang Gao et al. · 2023 · Signal Transduction and Targeted Therapy
Review: Targeted therapy in renal cancer
Tanya Barauskas Dorff, Amir Goldkorn, David I. Quinn · 2009 · Therapeutic Advances in Medical Oncology
Tuberous Sclerosis Complex 1: An Epithelial Tumor Suppressor Essential to Prevent Spontaneous Prostate Cancer in Aged Mice
Raleigh D. Kladney, Robert D. Cardiff, David J. Kwiatkowski, Gary Gene Chiang, Jason D. Weber, Jeffrey M. Arbeit, Zhi Hong Lu · 2010 · Cancer Research
Morphoproteomic confirmation of a constitutively activated mTOR pathway in high grade prostatic intraepithelial neoplasia and prostate cancer.
Robert Eldon Brown, George Zotalis, Ping L. Zhang, Bihong Zhao · 2008 · PubMed Central
A Spontaneous Acinar Cell Carcinoma Model for Monitoring Progression of Pancreatic Lesions and Response to Treatment Through Noninvasive Bioluminescence Imaging
Ning Zhang, Scott K. Lyons, Ed Lim, Peter Lassota · 2009 · Clinical Cancer Research
Cross-species comparisons of cancer signaling
Thomas G. Graeber, Charles L. Sawyers · 2004 · Nature Genetics
Next generation of mammalian target of rapamycin inhibitors for the treatment of cancer
Valerie M. Nelson, Jessica Kaplan Altman, Leonidas C. Platanias · 2013 · Expert Opinion on Investigational Drugs
Antineoplastic effect of rapamycin is potentiated by inhibition of IRS-1 signaling in prostate cancer cells xenografts
Josenilson Campos de Oliveira, Kellen K. Souza, Marília M. Dias, Marcel C. Faria, Eduardo Rochete Ropelle, Marcelo B. S. Flores, Mirian Ueno, Licio Augusto Velloso, Sara Teresinha Olalla Saad, Mário J.A. Saad et al. · 2008 · Journal of Cancer Research and Clinical Oncology
The Suppression of Wound Healing Response with Sirolimus and Sunitinib Following Experimental Trabeculectomy in a Rabbit Model
Kenan Eren, Burak Turgut, Mehmet Mustafa Akin, Tamer Demır · 2015 · Current Eye Research
Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development
D. Alwyn Dart, Pinar Uysal Onganer, Wen G. Jiang · 2017 · Oncogenesis
Global Scenario of Research in Oral Cancer
Vinod Nair Sreekumar · 2018 · Journal of Maxillofacial and Oral Surgery
Alternate AChE-R variants facilitate cellular metabolic activity and resistance to genotoxic stress through enolase and RACK1 interactions
Inbal Mor, Tal Bruck, David Greenberg, Amit Berson, Letizia Schreiber, Dan Grisaru, Hermona Soreq · 2008 · Chemico-Biological Interactions
A versatile in vitro assay for investigating angiogenesis of the heart
Fabrice N. Kiefer, Veronica C. Munk, Rok Humar, Thomas Dieterle, Lukas Landmann, Edouard Battegay · 2004 · Experimental Cell Research
Analysis of complex protein kinase B signalling pathways in human prostate cancer samples
Verena Jendrossek, Marco Henkel, Jörg Hennenlotter, Ulrich H. Vogel, Ute Ganswindt, Ilka Müller, René Handrick, Aristoteles G. Anastasiadis, Markus Kuczyk, Arnulf Stenzl et al. · 2008 · British Journal of Urology
Chromosomal deletions in bladder cancer: shutting down pathways
Reimar Abraham · 2006 · Frontiers in bioscience
Recurrence of hepatocellular carcinoma after liver transplantation: Is immunosuppression a factor?
Myron Schwartz, Manoussos M. Konstadoulakis, Sasan Roayaie · 2005 · Liver Transplantation
AKR1C1 promotes non-small cell lung cancer proliferation via crosstalk between HIF-1α and metabolic reprogramming
Lin-Lin Chang, Pei‐Hua Lu, Wei Yang, Yan Wei Hu, Lin Zheng, Qiong Zhao, Nengming Lin, Wenzhou Zhang · 2022 · Translational Oncology
Crosstalk between hypoxic cellular micro-environment and the immune system: a potential therapeutic target for infectious diseases
Olalekan Chris Akinsulie, Sammuel Shahzad, Seto Charles Ogunleye, Ifeoluwa Peace Oladapo, Melina Joshi, Charles Egede Ugwu, Joy Olaoluwa Gbadegoye, Fasilat Oluwakemi Hassan, Richard Ayomide Adeleke, Qudus Afolabi Akande et al. · 2023 · Frontiers in Immunology
A novel injectable BRET-based in vivo imaging probe for detecting the activity of hypoxia-inducible factor regulated by the ubiquitin-proteasome system
Takahiro Kuchimaru, Tomoya Suka, Keisuke Hirota, Tetsuya Kadonosono, Shinae Kizaka‐Kondoh · 2016 · Scientific Reports
The Role of her2-Targeted Therapies in Women with her2-Overexpressing Metastatic Breast Cancer
Susan Faye Dent, S. Verma, Jean Latreille, Daniel Rayson, Mark J. Clemons, John Robert Mackey, S. Verma, Julie Lemieux, Louise Provencher, Stephen Chia et al. · 2009 · Current Oncology
Clinical Development of Phosphatidylinositol-3 Kinase Pathway Inhibitors
Carlos L. Arteaga · 2010 · Current topics in microbiology and immunology
Modeling Resistance to Pathway-Targeted Therapy in Ovarian Cancer
Deyin Xing, Sandra Oršulić · 2005 · Cell Cycle
Hepatocellular carcinoma and liver transplantation: clinical perspective on molecular targeted strategies
Yasunobu Matsuda, Takafumi Ichida, Manabu Fukumoto · 2011 · Medical Molecular Morphology
Advances in the treatment of prostate cancer with radiotherapy
Jaime Gómez‐Millán, Maria Fernanda Lara, R. Correa Generoso, A. Pérez-Rozos, Yolanda Lupiañez-Perez, José Antonio Medina Carmona · 2015 · Critical Reviews in Oncology/Hematology
Inhibition of mTORC1 Kinase Activates Smads 1 and 5 but Not Smad8 in Human Prostate Cancer Cells, Mediating Cytostatic Response to Rapamycin
Reema S. Wahdan-Alaswad, Kara L. Bane, Kyung W. Song, Dorjee T.N. Shola, Jorge Alberto Garcia, David Danielpour · 2012 · Molecular Cancer Research · Retracted
The clinical characteristics and molecular mechanism of pituitary adenoma associated with meningioma
Haibo Zhu, Yazhou Miao, Yutao Shen, Jing Guo, Weiyan Xie, Sida Zhao, Wei Dong, Yazhuo Zhang, Chuzhong Li · 2019 · Journal of Translational Medicine
Anti-Cancer Stem-Cell-Targeted Therapies in Prostate Cancer
Samantha Gogola, Michael Rejzer, Hisham F. Bahmad, Ferial Alloush, Yumna Omarzai, Robert Poppiti · 2023 · Cancers
Rapamycin Inhibits IGF-1-Mediated Up-Regulation of MDM2 and Sensitizes Cancer Cells to Chemotherapy
Wei Du, Yong Yi, Haibo Zhang, Johann S. Bergholz, Junfeng Wu, Haoqiang Ying, Yujun Zhang, Zhi‐Xiong Jim Xiao · 2013 · PLoS ONE
Genetically Engineered Murine Models of Prostate Cancer: Insights into Mechanisms of Tumorigenesis and Potential Utility
Sarki Abba Abdulkadir, Jongchan Kim · 2005 · Future Oncology
Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism
Zhivko Zhelev, Donika Ivanova, Rumiana Bakalova, Ichio Aoki, Tatsuya Higashi · 2016 · Anticancer Research
Oxygen and Iron Availability Shapes Metabolic Adaptations of Cancer Cells
Rui Wang, Aashiq Hussain, Quan Quan Guo, Xiao Wei Jin, Miao Miao Wang · 2024 · World Journal of Oncology
PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability
Lan Yu, Zeng‐Fu Shang, Jian Wang, Hongtao Wang, Fang Huang, Zhe Zhang, Ying Wang, Jianguang Zhou, Shanhu Li · 2015 · Oncotarget
Maternal Undernutrition Induces the Expression of Hypoxia-Related Genes in the Fetal Brain
Takuya Ito, Kiyoe Funamoto, Naoaki Sato, Ai Nakamura, Kaori Tanabe, Tetsuro Hoshiai, Kaori Suenaga, Junichi Sugawara, Satoru Nagase, Kunihiro Okamura et al. · 2011 · The Tohoku Journal of Experimental Medicine
Hypoxia and hypoxia‐inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula
Nirvana Sadaghianloo, Julie Contenti, Serge Declémy, Damien Ambrosetti, Maša Ždralević, Mounia Tannour‐Louet, Lucilla Fabbri, Gilles Pagès, Frédéric Bost, Réda Hassen‐Khodja et al. · 2021 · The Journal of Physiology
Triple-layer dissection of the lung adenocarcinoma transcriptome - regulation at the gene, transcript, and exon levels
Min-Kung Hsu, I-Ching Wu, Ching-Chia Cheng, Jen-Liang Su, Chang-Huain Hsieh, Yeong‐Shin Lin, Feng‐Chi Chen · 2015 · Oncotarget
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α
Ian N. Fleming, Alexandra Andriu, Timothy Smith · 2014 · Breast Cancer Research and Treatment
HIF-1α and NOTCH signaling in ductal and lobular carcinomas of the breast
Cigdem Ercan, Jeroen F. Vermeulen, Laurien D.C. Hoefnagel, Peter Bult, Petra van der Groep, Elsken van der Wall, P. J. van Diest · 2012 · Cellular Oncology